← FDA Drug Approvals (Drugs@FDA)

GLYCOPYRROLATE

NDA · New Drug Application · Sponsor: FRESENIUS KABI USA · Approved 2022-04-21

Drug application

FDA Application #

NDA214919

Application type

New Drug Application

Brand name

GLYCOPYRROLATE

Generic name

GLYCOPYRROLATE

Active ingredients

GLYCOPYRROLATE

Dosage form

SOLUTION

Route

INTRAMUSCULAR, INTRAVENOUS

Marketing status

Prescription

Sponsor

FRESENIUS KABI USA

Manufacturer

Fresenius Kabi USA, LLC

First approval

2022-04-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown